US EditionBiotech Stock Bounces From Support, Shows Relative Strength Amid Volatile Market
Summary by Investor's Business Daily
2 Articles
2 Articles
All
Left
Center
Right
1
Biotech Stock Bounces From Support, Shows Relative Strength Amid Volatile Market
Shares of biotech stock Halozyme found support at their 200-day line in a time where many stocks are below this level. The post Biotech Stock Bounces From Support, Shows Relative Strength Amid Volatile Market appeared first on Investor's Business Daily.
Biotech’s survival guide; What tariffs could mean for pharma; Congress pushes for $15B federal biotech investment; and more
Welcome back to Endpoints Weekly! This week's recap kicks off with Andrew Dunn's examination of the biotech playbook for surviving market turmoil. As former Alnylam CEO John Maraganore put it, recent events have "put biotech ...
Coverage Details
Total News Sources2
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
